138
1. Yannuzzi LA. Idiopathic polypoidal choroidal vasculopathy. The
Macula Society Meeting. Miami, USA, February 5, 1982. 1982; 1.
2. Kleiner RC, Brucker AJ, Johnston RL. The posterior uveal
bleeding syndrome. Retina 1990; 10 (1): 9-17.
3. Stern RM, Zakov ZN, Zegarra H, Gutman FA. Multiple recurrent
serosanguineous retinal pigment epithelial detachments in black
women. Am J Ophthalmol 1985; 100 (4): 560-569.
4. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA.
Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004; 49
(1): 25-37.
5. Wen F, Chen C, Wu D, Li H. Polypoidal choroidal vasculopathy
in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol
2004; 242 (8): 625-629.
6. Guyomarch J, Jean-Charles A, Acis D, Donnio A, Richer R, Merle
H. Vasculopathie polypoidale choroidienne idiopathique: aspects
cliniques et angiographiques. J Fr Ophtalmol 2008; 31 (6 Pt 1):
579-584.
7. Scassellati-Sforzolini B, Mariotti C, Bryan R, Yannuzzi LA,
Giuliani M, Giovannini A. Polypoidal choroidal vasculopathy in
Italy. Retina 2001; 21 (2): 121-125.
8. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal
choroidal vasculopathy. Br J Ophthalmol 2005; 89 (5): 602-607.
9. MacCumber MW, Dastgheib K, Bressler NM, Chan CC, Harris
M, Fine S, Green WR. Clinicopathologic correlation of the
multiple recurrent serosanguineous retinal pigment epithelial
detachments syndrome. Retina 1994; 14 (2): 143-152.
10. Lafaut BA, Leys AM, Snyers B,
et al.
. Polypoidal choroidal
vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol
2000;238:752–9.
11. Rosa RH, Jr., Davis JL, Eifrig CW. Clinicopathologic reports,
case reports, and small case series: clinicopathologic correlation of
idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol
2002; 120 (4): 502-508.
12. Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N.
Clinicopathological correlation of polypoidal choroidal
vasculopathy revealed by ultrastructural study. Br J Ophthalmol
2002; 86 (10): 1093-1098.
13. Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka
T. Polypoidal choroidal vasculopathy treated with macular
translocation: clinical pathological correlation. Br J Ophthalmol
2002; 86 (3): 321-327.
14. Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura
A, Mori R, Yuzawa M. Clinicopathologic findings in polypoidal
choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49 (11):
4729-4737.
15. Okubo A, Hirakawa M, Ito M, Sameshima M, Sakamoto T.
Clinical features of early and late stage polypoidal choroidal
vasculopathy characterized by lesion size and disease duration.
Graefes Arch Clin Exp Ophthalmol 2008; 246 (4): 491-499.
16. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA.
Indocyanine green videoangiography of idiopathic polypoidal
choroidal vasculopathy. Retina 1995; 15 (2): 100-110.
17. Silva RM, Figueira J, Cachulo ML, Duarte L, Faria dA, Jr., Cunha-
References
Vaz JG. Polypoidal choroidal vasculopathy and photodynamic
therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol
2005; 243 (10): 973-979.
18. Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC,
Spaide RF, Freund KB, Slakter JS, Guyer DR, Sorenson JA, Fisher
Y, Maberley D, Orlock DA. Polypoidal choroidal vasculopathy
and neovascularized age-related macular degeneration. Arch
Ophthalmol 1999; 117 (11): 1503-1510.
19. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock
DA. The expanding clinical spectrum of idiopathic polypoidal
choroidal vasculopathy. Arch Ophthalmol 1997; 115 (4): 478-
485.
20. Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC.
Polypoidal choroidal vasculopathy in exudative and haemorrhagic
pigment epithelial detachments. Br J Ophthalmol 2000; 84 (5):
479-484.
21. Kondo N, Honda S, Kuno S, Negi A. Coding variant I62V in the
complement factor H gene is strongly associated with polypoidal
choroidal vasculopathy. Ophthalmology 2009; 116 (2): 304-310.
22. Gotoh N, Nakanishi H, Hayashi H, Yamada R, Otani A,
Tsujikawa A, Yamashiro K, Tamura H, Saito M, Saito K, Iida
T, Matsuda F, Yoshimura N. ARMS2 (LOC387715) variants in
Japanese patients with exudative age-related macular degeneration
and polypoidal choroidal vasculopathy. Am J Ophthalmol 2009;
147 (6): 1037-1041.
23. Gotoh N, Yamada R, Nakanishi H, Saito M, Iida T, Matsuda F,
Yoshimura N. Correlation between CFH Y402H and HTRA1
rs11200638 genotype to typical exudative age-related macular
degeneration and polypoidal choroidal vasculopathy phenotype in
the Japanese population. Clin Experiment Ophthalmol 2008; 36
(5): 437-442.
24. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. Elastin gene
polymorphisms in neovascular age-related macular degeneration
and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci
2008; 49 (3): 1101-1105.
25. Ross RD, Gitter KA, Cohen G, Schomaker KS. Idiopathic
polypoidal choroidal vasculopathy associated with retinal arterial
macroaneurysm and hypertensive retinopathy. Retina 1996; 16
(2): 105-111.
26. Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H,
Fukushima I, Takahashi K, Matsumura M. Polypoidal choroidal
vasculopathy: natural history. Am J Ophthalmol 2002; 133 (5):
639-648.
27. Yang SS, Fu AD, McDonald HR, Johnson RN, Ai E, Jumper JM.
Massive spontaneous choroidal hemorrhage. Retina 2003; 23 (2):
139-144.
28. Kwok AK, Lai TY, Chan CW, Neoh EL, Lam DS. Polypoidal
choroidal vasculopathy in Chinese patients. Br J Ophthalmol
2002; 86 (8): 892-897.
29. Klais CM, Ciardella A, Yannuzzi LA. Polypoidal choroidal
vasculopathy. In: Virgil Alfaro D, Liggett PE, Mieler WF,
Quiroz-Mercado H, Jager RD, Tano Y, eds. Age-Related Macular
Degeneration: A Comprehensive Textbook. Philadelphia, USA.
Lippincott-Raven. 2006; 6: 53-63.
30. Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura
